Table of Contents
ISRN AIDS
Volume 2012, Article ID 485307, 5 pages
http://dx.doi.org/10.5402/2012/485307
Clinical Study

Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona

Department of Internal Medicine and Infectious Diseases, Hospital del Mar, 08003 Barcelona, Spain

Received 25 April 2012; Accepted 23 May 2012

Academic Editors: S. Blanche and P. Price

Copyright © 2012 Elisabet Lerma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. D. Thacher and B. L. Clarke, “Vitamin D insufficiency,” Mayo Clinic Proceedings, vol. 86, no. 1, pp. 50–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Holick, “Medical progress: vitamin D deficiency,” New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. F. DeLuca, “Overview of general physiologic features and functions of vitamin D,” The American Journal of Clinical Nutrition, vol. 80, pp. 1989S–1969S, 2004. View at Google Scholar · View at Scopus
  5. S. Christakos, P. Dhawan, Y. Liu, X. Peng, and A. Porta, “New insights into the mechanisms of vitamin D action,” Journal of Cellular Biochemistry, vol. 88, no. 4, pp. 695–705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Holick, “Vitamin D status: measurement, interpretation, and clinical application,” Annals of Epidemiology, vol. 19, no. 2, pp. 73–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. A. Bischoff-Ferrari, A. Shao, B. Dawson-Hughes, J. Hathcock, E. Giovannucci, and W. C. Willett, “Benefit-risk assessment of vitamin D supplementation,” Osteoporosis International, vol. 21, no. 7, pp. 1121–1132, 2010. View at Google Scholar · View at Scopus
  8. R. J. Singh, R. L. Taylor, G. S. Reddy, and S. K. G. Grebe, “C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3055–3061, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. W. Hollis, “Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D,” Journal of Nutrition, vol. 135, no. 2, pp. 317–322, 2005. View at Google Scholar · View at Scopus
  10. C. Brot, P. Vestergaard, N. Kolthoff, J. Gram, A. P. Hermann, and O. H. Sørensen, “Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone,” British Journal of Nutrition, vol. 86, supplement 1, pp. S97–S103, 2001. View at Google Scholar · View at Scopus
  11. C. M. Lenders, H. A. Feldman, E. Von Scheven et al., “Relation of body fat indexes to vitamin D status and deficiency among obese adolescents,” American Journal of Clinical Nutrition, vol. 90, no. 3, pp. 459–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Blum, G. Dolnikowski, E. Seyoum et al., “Vitamin D3 in fat tissue,” Endocrine, vol. 33, no. 1, pp. 90–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Pfeifer, B. Begerow, H. W. Minne, C. Abrams, D. Nachtigall, and C. Hansen, “Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women,” Journal of Bone and Mineral Research, vol. 15, no. 6, pp. 1113–1118, 2000. View at Google Scholar · View at Scopus
  14. M. Pfeifer, B. Begerow, H. W. Minne, K. Suppan, A. Fahrleitner-Pammer, and H. Dobnig, “Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals,” Osteoporosis International, vol. 20, no. 2, pp. 315–322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Lips, “Interaction between vitamin D and calcium,” Scandinavian Journal of Clinical and Laboratory Investigation, Supplementum, vol. 243, pp. 60–64, 2012. View at Google Scholar
  16. H. A. Bischoff-Ferrari, W. C. Willett, J. B. Wong et al., “Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials,” Archives of Internal Medicine, vol. 169, no. 6, pp. 551–561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Khosla, “What do we tell our patients about calcium and vitamin D supplementation?” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 69–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Milazzo, C. Mazzali, G. Bestetti et al., “Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population,” Current HIV Research, vol. 9, no. 3, pp. 186–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Mehta, E. Giovannucci, F. M. Mugusi et al., “Vitamin D status of HIV-infected women and its association with hiv disease progression, anemia, and mortality,” PLoS ONE, vol. 5, no. 1, Article ID e8770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. I. Choi, J. C. Lo, K. Mulligan et al., “Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons,” Clinical Infectious Diseases, vol. 52, no. 7, pp. 941–944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. N. Dao, P. Patel, E. T. Overton et al., “Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the us general population,” Clinical Infectious Diseases, vol. 52, no. 3, pp. 396–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kappor, “The role of vitamin D supplementation in HIV: an often forgotten perspective,” Climacteric, vol. 14, article 294, 2011. View at Google Scholar
  23. J. Fox, B. Peters, M. Prakash, J. Arribas, A. Hill, and C. Moecklinghoff, “Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial,” AIDS Research and Human Retroviruses, vol. 27, no. 1, pp. 29–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Yin and E. Stein, “The effects of TAR on vitamin,” Clinical Infectious Diseases, vol. 52, pp. 406–408, 2011. View at Google Scholar
  25. A. Pasquet, N. Viget, F. Ajana et al., “Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?” AIDS, vol. 25, no. 6, pp. 873–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Conesa-Botella, E. Florence, L. Lynen, R. Colebunders, J. Menten, and R. Moreno-Reyes, “Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen,” AIDS Research and Therapy, vol. 7, article 40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Mehta, F. M. Mugusi, D. Spiegelman et al., “Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania,” AIDS Patient Care STDS, vol. 25, no. 10, pp. 579–585, 2011. View at Publisher · View at Google Scholar
  28. J. P. Viard, J. C. Souberbielle, O. Kirk et al., “Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study,” AIDS, vol. 25, no. 10, pp. 1305–1315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Mueller, C. A. Fux, B. Ledergerber et al., “High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients,” AIDS, vol. 24, no. 8, pp. 1127–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. U. C. Bang, S. A. Shakar, M. F. Hitz et al., “Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study,” Scandinavian Journal of Infectious Diseases, vol. 42, no. 4, pp. 306–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. O. M. Adeyemi, D. Agniel, A. L. French et al., “Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States,” Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 3, pp. 197–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. G. Sweet, J. M. Sweet, M. P. Jeremiah, and S. S. Galazka, “Diagnosis and treatment of osteoporosis,” American Family Physician, vol. 79, no. 3, pp. 193–200, 2009. View at Google Scholar · View at Scopus
  33. A. C. Ross, J. E. Manson, S. A. Abrams et al., “The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Welz, K. Childs, F. Ibrahim et al., “Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase,” AIDS, vol. 24, no. 12, pp. 1923–1928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Caro-Murillo, A. Gil Luciano, G. Navarro Rubio, M. Leal Noval, and J. R. Blanco Ramos, “HIV infection in different age groups: potential implications for prevention. CoRIS Cohort, Spain, 2004–2008,” Medicina Clinica, vol. 134, no. 12, pp. 521–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. T. L. Clemens, J. S. Adams, S. L. Henderson, and M. F. Holick, “Increased skin pigment reduces the capacity of skin to synthesise vitamin D3,” The Lancet, vol. 1, no. 8263, pp. 74–76, 1982. View at Google Scholar · View at Scopus
  37. J. B. Koster and B. A. Künbauch, “Vitamin D deficiency and phsychiatrics patients,” Tijdschrift Voor Psychiatrie, vol. 53, pp. 561–565, 2011. View at Google Scholar
  38. A. Agorastos, A. Weinas, A. D. Agorastos, and K. Wiedemann, “Psychosis-induced vitamin D deficiency with secondary hyperparathyroidism and osteoporotic fractures,” General Hospital Psychiatry, vol. 33, pp. 641.e3–641.e5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Parker and H. Brotchie, “D for depression: any role for vitamin D? Food for Thought’ll,” Acta Psychiatrica Scandinavica, vol. 124, pp. 243–249, 2011. View at Publisher · View at Google Scholar
  40. J. R. Curtis, B. Smith, M. Weaver et al., “Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodistrophy,” AIDS Research and Human Retroviruses, vol. 22, pp. 125–131, 2006. View at Publisher · View at Google Scholar
  41. E. Hammond, E. McKinnon, P. Glendenning, R. Williams, S. Mallal, and E. Phillips, “Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV,” Clinical Endocrinology, vol. 76, pp. 201–206, 2012. View at Publisher · View at Google Scholar
  42. K. E. Childs, S. L. Fishman, C. Constable et al., “Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users,” AIDS Research and Human Retroviruses, vol. 26, no. 8, pp. 855–859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Masiá, S. Padilla, C. Robledano, N. López, J. M. Ramos, and F. Gutiérrez, “Early changes in parathyroid hormone concentrations in HIV-infectes patients initiating antiretroviral therapy with tenofovir,” AIDS Research and Human Retroviruses, vol. 28, no. 3, pp. 242–246, 2012. View at Publisher · View at Google Scholar
  44. P. L. Havens, C. B. Stephensen, and R. Hazra, “Vitamin D3 supplementation decreases parathyroid hormone (PTH) in HIV-infected youth being treated with tenofovir-containing combination antiretroviral therapy: randomized, double-blind, placebo-controlled trial,” Clinical Infectious Diseases, vol. 54, no. 7, pp. 1013–1025, 2012. View at Publisher · View at Google Scholar